Evaluation of gait disorders in children

Last reviewed: 25 Jun 2024
Last updated: 02 Apr 2024

Summary

Differentials

Common

  • Transient synovitis of the hip (toxic synovitis/irritable hip)
  • Toddler's fracture (spiral nondisplaced fracture of tibia with fibula intact)
  • Legg-Calve-Perthes disease
  • Nonaccidental injury
  • Osgood-Schlatter disease
  • Juvenile idiopathic arthritis (JIA)
  • Cerebral palsy
  • Spina bifida
  • Appendicitis
Full details

Uncommon

  • Slipped capital femoral epiphysis
  • Developmental hip dysplasia
  • Tarsal coalition
  • Sever disease
  • Spondylolysis
  • Juvenile dermatomyositis
  • Systemic lupus erythematosus (SLE)
  • Septic arthritis
  • Osteomyelitis
  • Charcot-Marie-Tooth (CMT) disease
  • Muscular dystrophies
  • Hemophilia
  • Sickle cell disease
  • Leukemia
  • Neuroblastoma
  • Benign bone tumor
  • Osteosarcoma
  • Ewing sarcoma
  • Rickets
  • Lysosomal storage disorders
  • Complex regional pain syndrome
Full details

Contributors

Authors

Sharmila Jandial, MBChB, MRCPCH, Cert Med Ed

Consultant Paediatric Rheumatologist

Great North Children’s Hospital

Newcastle upon Tyne

UK

Disclosures

SJ declares that she has no competing interests.

Sophie Whyte, MBBS, MRCPCH

Paediatric Neurodisability ST7 Registrar

Great North Children's Hospital

Newcastle upon Tyne

UK

Disclosures

SE declares that she has no competing interests.

Acknowledgements

Dr Sharmila Jandial and Dr Sophie Whyte would like to gratefully acknowledge Prof Helen Foster and Dr Paula Drummond, previous contributors to this topic.

Disclosures

PD declares that she has no competing interests. HF has received unrestricted educational research grants from Pfizer, BioMarin, Sobi, and Genzyme to develop educational materials. HF has also received honoraria (e.g., for chairing of workshops at conferences) and served on advisory boards for Genzyme, BioMarin, and Pfizer; she has given any proceeds from this work to Newcastle University, UK to support her research activities.

Peer reviewers

Jacqui Clinch, MB BS

Consultant Paediatric Rheumatologist

Bristol Royal Hospital for Children

Bristol

UK

Disclosures

JC declares that she has no competing interests.

Mark Wood, MB BS

Consultant Paediatric and Adolescent Rheumatologist

Leeds General Infirmary

Leeds

UK

Disclosures

MW declares that he has no competing interests.

Sherilyn Driscoll, MD

Consultant

Assistant Professor

Mayo Medical School

Program Director

Pediatric Rehabilitation Medicine

Mayo Clinic

Rochester

MN

Disclosures

SD declares that she has no competing interests.

Use of this content is subject to our disclaimer